Besides these, anti-vascular treatment on the basis of tumor vessel infarction could be further studied. Without doubt, poor survival rates of SCLC patients raise the need for new therapeutic principles. References 1. Ferlay, J.; Soerjomataram, I.; Dikshit, R.; Eser, S.; Mathers, C.; ...